Tag Archives: Edward White

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (NASDAQ: ALRN) and vTv Therapeutics (NASDAQ: VTVT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aileron Therapeutics (ALRN – Research Report) and vTv Therapeutics (VTVT – Research Report) with bullish sentiments. Aileron Therapeutics (ALRN) H.C. Wainwright analyst

Analysts’ Top Healthcare Picks: G1 Therapeutics (GTHX), Roche Holding AG (RHHVF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on G1 Therapeutics (GTHX – Research Report) and Roche Holding AG (RHHVF – Research Report) with bullish sentiments. G1 Therapeutics (GTHX) In a

Spectrum Pharmaceuticals (SPPI) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Edward White reiterated a Buy rating on Spectrum Pharmaceuticals (SPPI – Research Report) today and set a price target of $13.00. The company’s shares closed last Monday at $2.95, close to its 52-week low of $1.74. According

Aileron Therapeutics (ALRN) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Edward White maintained a Buy rating on Aileron Therapeutics (ALRN – Research Report) today and set a price target of $2.00. The company’s shares closed last Monday at $1.14. According to TipRanks.com, White is a top 100

Dynavax (DVAX) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Edward White maintained a Buy rating on Dynavax (DVAX – Research Report) today and set a price target of $12.00. The company’s shares closed last Thursday at $6.13. According to TipRanks.com, White is a top 100 analyst

IDEAYA Biosciences (IDYA) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Edward White maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) today and set a price target of $13.00. The company’s shares closed last Friday at $8.04. According to TipRanks.com, White is a top 100